Publications:

Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas.

Genome Medicine

Berrino, Enrico E; Annaratone, Laura L; Bellomo, Sara Erika SE; Ferrero, Giulio G; Gagliardi, Amedeo A; Bragoni, Alberto A; Grassini, Dora D; Guarrera, Simonetta S; Parlato, Caterina C; Casorzo, Laura L; Panero, Mara M; Sarotto, Ivana I; Giordano, Silvia S; Cereda, Matteo M; Montemurro, Filippo F; Ponzone, Riccardo R; Crosetto, Nicola N; Naccarati, Alessio A; Sapino, Anna A; Marchiò, Caterina C

Publication Date: 2022-08-29

Variant appearance in text: TET1: 1102G>C; Ala368Pro

PubMed Link: 36038884

Variant Present in the following documents:

• 13073_2022_1104_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page

Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis.

Leukemia

Schatz, J H JH; Horwitz, S M SM; Teruya-Feldstein, J J; Lunning, M A MA; Viale, A A; Huberman, K K; Socci, N D ND; Lailler, N N; Heguy, A A; Dolgalev, I I; Migliacci, J C JC; Pirun, M M; Palomba, M L ML; Weinstock, D M DM; Wendel, H-G HG

Publication Date: 2015-01

Variant appearance in text: TET1: A368P

PubMed Link: 25257991

Variant Present in the following documents:

• Main text
• leu2014261a.pdf

View BVdb publication page